The ANZICS Clinical Trials Group 20th Annual Meeting on Clinical Trials in Intensive Care will be held from Tuesday March 6th - Thursday March 8th, 2018, at the Sofitel Noosa Pacific Resort, Noosa, Queensland, Australia.
The ANZICS Paediatric Study Group Meeting will be held on Sunday March 4th and the ICU Research Coordinator Workshop will be held on Monday March 5th, 2018.
The Annual Meeting on Clinical Trials in Intensive Care, or "Noosa", has long been regarded as a pivotal event on the CTG's calendar. This working meeting provides a forum for the presentation, discussion, and development of intensive care research proposals, the presentation of results and updates on current CTG studies, and didactic elements centred on the advancement of clinical research methods in critical illness. For those with an emerging or established interest in critical care research, the Noosa meeting is an opportunity to be an active member of the CTG network and benefit from the collective experience and expertise of the trials group.
The annual ICU Research Coordinator Workshop is a unique and highly-valuable education forum and provides an opportunity for ICU Research Coordinators to network, share ideas and experiences, and further the development of research coordination as a specialised area of critical care research.
The Paediatric Study Group Meeting provides the opportunity for members of the Paediatric research community to gather and discuss current research topics and issues particular to Paediatric research.
Members of the intensive care research community and individuals working in the public sector (i.e. in a non-commercial setting) to improve outcomes for people with critical illness are invited to attend the meetings.
We are pleased to announce that Prof J Perren Cobb will be our key note speaker at the ANZICS CTG 20th Annual Meeting. Perren is one of the preeminent experts in the field of critical care surgery and medicine and is Director of the surgical intensive care unit at Keck Medical Center. He is the Founding Director of the United States Critical Illness and Injury Trials Group (USCIIT) and heads the USC Critical Care Institute, both of which are geared toward improving outcomes for the critically ill and injured through transformative biomedical research and performance improvement.
Please note that in 2018 delegate numbers will be limited 250. Please register early to avoid disappointment.